Standout Papers

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis 2017 2026 2020 2023 406
  1. Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis (2017)
    Thomas Ruzicka, Jon M. Hanifin et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 81 standout
Sub-graph 1 of 19

Citing Papers

Type 2 cytokine signaling in macrophages protects from cellular senescence and organismal aging
2024 Standout
Dual-Site Biomimetic Cu/Zn-MOF for Atopic Dermatitis Catalytic Therapy via Suppressing FcγR-Mediated Phagocytosis
2024 Standout
13 intermediate papers

Works of Ryosuke Mihara being referenced

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
2017 Standout
The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co
2015
and 2 more

Author Peers

Author Last Decade Papers Cites
Ryosuke Mihara 53 32 36 692 480 21 828
Mogens Krøigaard 58 6 20 385 508 24 771
Y.M.F. Andersen 2 2 13 664 418 32 829
Judith L. Thijs 1 17 812 640 31 938
Daphne S. Bakker 1 12 599 442 33 665
Jan Walter Schroeder 32 8 102 208 354 32 714
Z. Chen 9 666 538 20 725
Harold S. Nelson 21 9 374 157 259 13 916
Natalija Novak 13 626 582 21 847
M. Di Fonso 2 56 419 427 30 902
Susana Marinho 44 19 178 190 425 26 803

All Works

Loading papers...

Rankless by CCL
2026